HBM Holdings Limited (2142.HK)

HKD 7.66

(-1.42%)

EBITDA Summary of HBM Holdings Limited

  • HBM Holdings Limited's latest annual EBITDA in 2023 was 31.18 Million USD , up 127.88% from previous year.
  • HBM Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 496 Thousand USD , down 0.0% from previous quarter.
  • HBM Holdings Limited reported an annual EBITDA of -115.5 Million USD in 2022, up 11.85% from previous year.
  • HBM Holdings Limited reported an annual EBITDA of -130.84 Million USD in 2021, up 54.96% from previous year.
  • HBM Holdings Limited reported a quarterly EBITDA of 496 Thousand USD for 2024 Q2, down 0.0% from previous quarter.
  • HBM Holdings Limited reported a quarterly EBITDA of 9.17 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of HBM Holdings Limited (2023 - 2018)

Historical Annual EBITDA of HBM Holdings Limited (2023 - 2018)

Year EBITDA EBITDA Growth
2023 31.18 Million USD 127.88%
2022 -115.5 Million USD 11.85%
2021 -130.84 Million USD 54.96%
2020 -290.91 Million USD -362.57%
2019 -62.89 Million USD -90.47%
2018 -33.01 Million USD 0.0%

Peer EBITDA Comparison of HBM Holdings Limited

Name EBITDA EBITDA Difference
Uni-Bio Science Group Limited 91.23 Million HKD 65.819%
CK Life Sciences Int'l., (Holdings) Inc. 486.79 Million HKD 93.594%